Device-assisted intravesical chemotherapy versus bacillus Calmette-Guerin for intermediate or high-risk non-muscle invasive bladder cancer: a systematic reviewer and meta-analysis.

Chengyu YouQingchao LiLiangliang QingRongxin LiYanan WangLong ChengZhilong Dong

Published in: International urology and nephrology (2023)

Device-assisted intravesical chemotherapy appears to be a safe and viable alternative to BCG for patients with intermediate and high-risk NMIBC, showing comparable oncological outcomes and adverse events.

Keyphrases

muscle invasive bladder cancer
locally advanced
rectal cancer
squamous cell carcinoma
radical prostatectomy
radiation therapy
prostate cancer
chemotherapy induced
type diabetes
adipose tissue
robot assisted
metabolic syndrome
insulin resistance
bacillus subtilis
skeletal muscle